Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.

MLA

Caroff, Stanley N., et al. “Intravenous Dantrolene in Hypermetabolic Syndromes: A Survey of the U.S. Veterans Health Administration Database.” BMC Anesthesiology, vol. 22, no. 1, Sept. 2022, p. 298. EBSCOhost, https://doi.org/10.1186/s12871-022-01841-z.

APA

Caroff, S. N., Roberts, C. B., Rosenberg, H., Tobin, J. R., Watt, S., Mashman, D., Riazi, S., & Berkowitz, R. M. (2022). Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database. BMC Anesthesiology, 22(1), 298. https://doi.org/10.1186/s12871-022-01841-z

Chicago

Caroff, Stanley N, Christopher B Roberts, Henry Rosenberg, Joseph R Tobin, Stacey Watt, Darlene Mashman, Sheila Riazi, and Rosalind M Berkowitz. 2022. “Intravenous Dantrolene in Hypermetabolic Syndromes: A Survey of the U.S. Veterans Health Administration Database.” BMC Anesthesiology 22 (1): 298. doi:10.1186/s12871-022-01841-z.